Extrapulmonary Interventional Ventilatory Support for Lung Protection in Severe Acute Respiratory Distress - a Prospective Randomized Multi Centre Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Respiratory Distress Syndrome
- Sponsor
- University of Regensburg
- Enrollment
- 120
- Locations
- 1
- Primary Endpoint
- Ventilator free days within 28 days after enrollment
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
A prospective, randomized study will be performed investigating the effects of a pumpless extracorporeal interventional lung assist [iLA] on the implementation of a lung-protective ventilatory strategy in patients with acute respiratory distress syndrome [ARDS] with a PaO2/FiO2 ratio < 200. The duration of ventilation, intensive care and hospital stay and in-hospital mortality will be investigated.
Detailed Description
Evaluation group: Implantation of the iLA - adaptation of the ventilation strategy, explantation of the iLA after corresponding improvement (see treatment plan for details) - weaning from the ventilation and extubation according to specified criteria. Control group: Ventilation strategy based on the concept of lung-protective ventilation without extracorporeal support, weaning from the ventilation and extubation according to specified criteria (see treatment plan for details).
Investigators
Eligibility Criteria
Inclusion Criteria
- •The trial subjects are patients aged 18 years or older who have developed severe ARDS. Following the American-European Consensus Conference on ARDS, severe ARDS is defined as an oxygenation index (PaO2/FIO2) \< 200 mmHg. These parameters must be present for a duration of at least 2 hours.
Exclusion Criteria
- •age \< 18 years
- •decompensated heart insufficiency
- •acute coronary syndrome
- •severe chronic obstructive pulmonary disease
- •advanced tumour conditions with life expectancy \< 6 months
- •chronic dialysis treatment
- •lung transplant patients
- •proven Heparin-induced thrombocytopenia (HIT)
- •morbid obesity (BMI \>) 40
- •Child Class B and C cirrhosis of the liver, acute fulminant hepatic failure
Outcomes
Primary Outcomes
Ventilator free days within 28 days after enrollment
Time Frame: 28 days
Secondary Outcomes
- hospital mortality, organ-failure free days, pulmonary gas exchange(28 days - 60 days)